0 CHECKOUT

Acceleron Pharma, Inc. - Product Pipeline Review - 2015

  • ID: 3280626
  • May 2015
  • 45 pages
  • Global Markets Direct
1 of 3

Acceleron Pharma, Inc. - Product Pipeline Review - 2015

Summary

This, ‘Acceleron Pharma, Inc. - Product Pipeline Review - 2015’, provides an overview of the Acceleron Pharma, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Acceleron Pharma, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following READ MORE >

Note: Product cover images may vary from those shown
2 of 3

List of Tables
List of Figures
Acceleron Pharma, Inc. Snapshot
Acceleron Pharma, Inc. Overview
Key Information
Key Facts
Acceleron Pharma, Inc. - Research and Development Overview
Key Therapeutic Areas
Acceleron Pharma, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Acceleron Pharma, Inc. - Pipeline Products Glance
Acceleron Pharma, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Acceleron Pharma, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Acceleron Pharma, Inc. - Drug Profiles
dalantercept
Product Description
Mechanism of Action
R&D Progress
luspatercept
Product Description
Mechanism of Action
R&D Progress
sotatercept
Product Description
Mechanism of Action
R&D Progress
ACE-083
Product Description
Mechanism of Action
R&D Progress
ACE-661
Product Description
Mechanism of Action
R&D Progress
ACE-772
Product Description
Mechanism of Action
R&D Progress
ALKS-693
Product Description
Mechanism of Action
R&D Progress
Protein for Bone Disorders
Product Description
Mechanism of Action
R&D Progress
Protein for Fibrosis
Product Description
Mechanism of Action
R&D Progress
Protein for Muscle Disorders
Product Description
Mechanism of Action
R&D Progress
Protein for Skin Disease
Product Description
Mechanism of Action
R&D Progress
Acceleron Pharma, Inc. - Pipeline Analysis
Acceleron Pharma, Inc. - Pipeline Products by Target
Acceleron Pharma, Inc. - Pipeline Products by Route of Administration
Acceleron Pharma, Inc. - Pipeline Products by Molecule Type
Acceleron Pharma, Inc. - Pipeline Products by Mechanism of Action
Acceleron Pharma, Inc. - Recent Pipeline Updates
Acceleron Pharma, Inc. - Dormant Projects
Acceleron Pharma, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
ramatercept
Acceleron Pharma, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Acceleron Pharma, Inc., Key Information
Acceleron Pharma, Inc., Key Facts
Acceleron Pharma, Inc. - Pipeline by Indication, 2015
Acceleron Pharma, Inc. - Pipeline by Stage of Development, 2015
Acceleron Pharma, Inc. - Monotherapy Products in Pipeline, 2015
Acceleron Pharma, Inc. - Phase II, 2015
Acceleron Pharma, Inc. - Phase I, 2015
Acceleron Pharma, Inc. - Preclinical, 2015
Acceleron Pharma, Inc. - Pipeline by Target, 2015
Acceleron Pharma, Inc. - Pipeline by Route of Administration, 2015
Acceleron Pharma, Inc. - Pipeline by Molecule Type, 2015
Acceleron Pharma, Inc. - Pipeline Products by Mechanism of Action, 2015
Acceleron Pharma, Inc. - Recent Pipeline Updates, 2015
Acceleron Pharma, Inc. - Dormant Developmental Projects,2015
Acceleron Pharma, Inc. - Discontinued Pipeline Products, 2015

List of Figures
Acceleron Pharma, Inc. - Pipeline by Top 10 Indication, 2015
Acceleron Pharma, Inc. - Pipeline by Stage of Development, 2015
Acceleron Pharma, Inc. - Monotherapy Products in Pipeline, 2015
Acceleron Pharma, Inc. - Pipeline by Top 10 Target, 2015
Acceleron Pharma, Inc. - Pipeline by Top 10 Route of Administration, 2015
Acceleron Pharma, Inc. - Pipeline by Top 10 Molecule Type, 2015
Acceleron Pharma, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.